Latest Tax Implications on Pharma

Vaccine development, a presidential election, and IRS activity are among some of the concerns facing organizations within the pharmaceutical industry – and their tax outlook.

The Latest Tax Implications on Pharma special report provides you insight for effective decision-making across one of the most significant catalysts on the path to pandemic recovery.

Explore the following key pharmaceutical concerns:

• Indonesia’s R&D tax deductions related to vaccine development
• Considerations for maximizing virtual mediation in a practice likely to continue beyond the pandemic
• Path to economic recovery and impact of the Trump vs. Biden presidential race
• Benefits to pharmaceutical companies of government investments in research
• Strategies multinationals use to lower U.S. tax bills and the relevance of Section 704(c) and Section 721

Download your copy to strengthen your insight and inform your stakeholders.